UTHR fund manager activity
United Therapeutics Corporation · Nasdaq. Reported by 7 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 33,836 | $18,333,583 | 0.01% | Aug 4, 2026 |
| Jeremy Grantham - GMO | Trimmed | 3,277 | $1,775,577 | 0.00% | Aug 13, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 79,123 | $42,871,215 | 0.10% | Aug 14, 2026 |
| Mairs & Power Funds | Sold out | — | — | 0.00% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Added | 34,404 | $20,400,941 | 0.01% | May 5, 2026 |
| Jeremy Grantham - GMO | Added | 3,452 | $2,046,967 | 0.01% | May 14, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 80,387 | $47,667,883 | 0.15% | May 15, 2026 |
| Mairs & Power Funds | New | 350 | $207,543 | 0.00% | May 14, 2026 |
Older quarters